Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Therapeutics and Clinical Risk Management|August 4, 2017
Thyroid cancer in a patient with Lynch syndrome - case report and literature reviewMonika Fazekas-Lavu, Andrew Parker, Allan D Spigelman, et al.Journal of Clinical Neuromuscular Disease|April 28, 2012
Clinical and imaging findings in three patients with advanced inflammatory demyelinating polyradiculoneuropathy associated with nerve root hypertrophySaid R Beydoun, Jason Muir, Rami G Apelian, et al.Acta Oncologica (Stockholm, Sweden)|April 1, 2003
Quick-FLIC--a short questionnaire for assessing quality of life of cancer patientsYin-Bun Cheung, Kei-Siong Khoo, Zee-Wan Wong, et al.Pathology Oncology Research : POR|August 21, 2009
PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic successHilda Wong, Thomas Yau, Pierre Chan, et al.Oncology|December 22, 2007
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinomaThomas Yau, Pierre Chan, Hilda Wong, et al.Studies in Health Technology and Informatics|August 8, 2025
Automating Precision Oncology Literature Curation: A Decision Tree Approach Using Large Language ModelsFrank P Lin, Minh Tran, Subotheni Thavaneswaran, et al.Oncogene|July 16, 2002
Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antiseraDongsheng Chen, Elinor Washbrook, Naveed Sarwar, et al.Clinical and Translational Medicine|April 17, 2024
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databasesImogen R Walpole, Farzana Y Zaman, Peinan Zhao, et al.NPJ Precision Oncology|June 24, 2021
Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncologyFrank P Lin, Subotheni Thavaneswaran, John P Grady, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinomaThomas E Hutson, Ian D Davis, Jean-Pascal H Machiels, et al.Pageof 7